Asthma


Fda Approves New Iv Asthma Drug, Cinqair

The U.S. Food and Drug Administration (FDA) recently approved Teva Pharmaceuticals’ Cinqair (reslizumab), an intravenous (IV) infusion used in adult patients 18 years and older…


Singulair | Montelukast Sodium

1.1 Asthma SINGULAIR® is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. 1.2 Exercise-Induced…


Proventil Hfa | Albuterol Sulfate

PROVENTIL® HFA Inhalation Aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible…


Asmanex Hfa | Mometasone Furoate

1.1 Treatment of Asthma ASMANEX® HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older….


Albuterol Sulfate

Albuterol Sulfate Syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease….


Levalbuterol

Levalbuterol inhalation solution USP is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with…


Ipratropium Bromide And Albuterol Sulfate

Ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator. contraindications…


Budesonide

1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to…


Levalbuterol Hydrochloride

Levalbuterol HCl inhalation solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with…


Budesonide Inhalation | Budesonide

1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to…